BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14747616)

  • 1. Oxidation of protein tyrosine phosphatases as a pharmaceutical mechanism of action: a study using 4-hydroxy-3,3-dimethyl-2H-benzo[g]indole-2,5(3H)-dione.
    Liljebris C; Baranczewski P; Björkstrand E; Byström S; Lundgren B; Tjernberg A; Warolén M; James SR
    J Pharmacol Exp Ther; 2004 May; 309(2):711-9. PubMed ID: 14747616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation.
    Denu JM; Tanner KG
    Biochemistry; 1998 Apr; 37(16):5633-42. PubMed ID: 9548949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain-mediated degradation of reversibly oxidized protein-tyrosine phosphatase 1B.
    Trümpler A; Schlott B; Herrlich P; Greer PA; Böhmer FD
    FEBS J; 2009 Oct; 276(19):5622-33. PubMed ID: 19712109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An antibody-based method for monitoring in vivo oxidation of protein tyrosine phosphatases.
    Persson C; Kappert K; Engström U; Ostman A; Sjöblom T
    Methods; 2005 Jan; 35(1):37-43. PubMed ID: 15588984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
    Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
    Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice.
    Mueller AS; Pallauf J
    J Nutr Biochem; 2006 Aug; 17(8):548-60. PubMed ID: 16443359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox regulation of SH2-domain-containing protein tyrosine phosphatases by two backdoor cysteines.
    Chen CY; Willard D; Rudolph J
    Biochemistry; 2009 Feb; 48(6):1399-409. PubMed ID: 19166311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis.
    Kappert K; Sparwel J; Sandin A; Seiler A; Siebolts U; Leppänen O; Rosenkranz S; Ostman A
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2644-51. PubMed ID: 16990553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a supranutritional dose of selenate compared with selenite on insulin sensitivity in type II diabetic dbdb mice.
    Müller AS; Most E; Pallauf J
    J Anim Physiol Anim Nutr (Berl); 2005; 89(3-6):94-104. PubMed ID: 15787978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein tyrosine phosphatases and signalling.
    Stoker AW
    J Endocrinol; 2005 Apr; 185(1):19-33. PubMed ID: 15817824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
    Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
    Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele-specific inhibitors of protein tyrosine phosphatases.
    Hoffman HE; Blair ER; Johndrow JE; Bishop AC
    J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants.
    Haase H; Maret W
    Biometals; 2005 Aug; 18(4):333-8. PubMed ID: 16158225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative modification of protein tyrosine phosphatases.
    Wu RF; Terada LS
    Sci STKE; 2006 Apr; 2006(332):pl2. PubMed ID: 16639034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast substrate-trapping system for isolating substrates of protein tyrosine phosphatases: Isolation of substrates for protein tyrosine phosphatase receptor type z.
    Fukada M; Kawachi H; Fujikawa A; Noda M
    Methods; 2005 Jan; 35(1):54-63. PubMed ID: 15588986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical and mechanistic approaches to the study of protein tyrosine phosphatases.
    Zhang ZY
    Acc Chem Res; 2003 Jun; 36(6):385-92. PubMed ID: 12809524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of protein tyrosine phosphatases by amino acid, peptide, and protein hydroperoxides: potential modulation of cell signaling by protein oxidation products.
    Gracanin M; Davies MJ
    Free Radic Biol Med; 2007 May; 42(10):1543-51. PubMed ID: 17448901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyrtiosal, a PTP1B inhibitor from the marine sponge Hyrtios erectus, shows extensive cellular effects on PI3K/AKT activation, glucose transport, and TGFbeta/Smad2 signaling.
    Sun T; Wang Q; Yu Z; Zhang Y; Guo Y; Chen K; Shen X; Jiang H
    Chembiochem; 2007 Jan; 8(2):187-93. PubMed ID: 17183521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of protein tyrosine phosphatases and dual-specificity phosphatases in mammalian spermatozoa and their role in sperm motility and protein tyrosine phosphorylation.
    González-Fernández L; Ortega-Ferrusola C; Macias-Garcia B; Salido GM; Peña FJ; Tapia JA
    Biol Reprod; 2009 Jun; 80(6):1239-52. PubMed ID: 19211810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
    Camilleri AA; Willmann R; Sadasivam G; Lin S; Rüegg MA; Gesemann M; Fuhrer C
    BMC Neurosci; 2007 Jul; 8():46. PubMed ID: 17605785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.